LRP5, short for Low-density lipoprotein receptor-related protein 5, is a member of the low-density lipoprotein (LDL) receptor family. These receptors play crucial roles in various cellular processes, such as signal transduction, endocytosis, and the regulation of cellular uptake of cholesterol. As their name implies, LRP5 activators are chemical compounds that specifically target and enhance the activity or signaling pathways associated with LRP5. The mechanism by which these activators function might involve direct interaction with the protein or indirectly by modulating other proteins or molecules that regulate LRP5 function.
One of the fascinating aspects of LRP5's biochemistry is its involvement in the Wnt signaling pathway. The Wnt signaling pathway is a complex network of proteins that play a significant role in embryonic development, cell differentiation, and cell proliferation. When Wnt ligands bind to their respective receptors, such as the Frizzled family of receptors, they initiate a cascade of intracellular events. LRP5, along with its closely related protein LRP6, acts as a co-receptor in the Wnt signaling pathway. The interaction between Wnt, Frizzled, and LRP5/6 leads to the stabilization of beta-catenin, a key intracellular mediator in the pathway. Therefore, the modulation of LRP5 activity by its activators can significantly influence the outcome of the Wnt signaling pathway. Understanding the chemical characteristics and interactions of LRP5 activators not only sheds light on the intricacies of molecular signaling but also opens up avenues for studying cellular processes at a granular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
A potent and selective GSK3 inhibitor known to activate the Wnt/β-catenin pathway by inhibiting GSK3, an enzyme that phosphorylates and destabilizes β-catenin. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Another specific GSK3 inhibitor. Like BIO, it prevents the phosphorylation of β-catenin, leading to the accumulation and activation of the Wnt/β-catenin pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
An inhibitor of GSK3β, LiCl has been used to activate the Wnt/β-catenin pathway in several experimental models. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid that has been suggested to activate the Wnt/β-catenin pathway, potentially impacting LRP5. | ||||||